TOI - NASDAQ

The Oncology Institute, Inc.

TOI·NASDAQ

$4.23

-7.8%

HealthcareMedical - Care Facilities

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$422.93M

EPS-0.5400

P/E Ratio-7.83

Earnings Date08/12/2026

toi

Net Cash Provided by Financing Activities

Last Annual Value

11.56M

3-Year CAGR

-50%

5-Year CAGR

-1%

10-Year CAGR

13%

Adjust for Inflation

The Oncology Institute, Inc. Competitors Analysis of Net Cash Provided by Financing Activities

TOI · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
The Oncology Institute, Inc. NASDAQ:TOI	11.56M	N/A	-40.4%	N/A
OrthoPediatrics Corp. NASDAQ:KIDS	23.98M	48.6%	425.2%	20.9%
Treace Medical Concepts, Inc. NASDAQ:TMCI	2.08M	-73.3%	-54.6%	N/A
Aura Biosciences, Inc. NASDAQ:AURA	77.16M	-7.4%	-14.2%	N/A
Community Health Systems, Inc. NYSE:CYH	-1.17B	N/A	N/A	N/A
Design Therapeutics, Inc. NASDAQ:DSGN	25.74M	228.8%	-41.6%	N/A
Semler Scientific, Inc. NASDAQ:SMLR	117.19M	N/A	518.0%	45.1%
Talkspace, Inc. NASDAQ:TALK	-19.00M	N/A	N/A	N/A
Perspective Therapeutics, Inc. AMEX:CATX	10.30M	135.9%	183.8%	N/A
Senseonics Holdings, Inc. NASDAQ:SENS	78.19M	56.6%	-18.7%	3.6%
Cross Country Healthcare, Inc. NASDAQ:CCRN	-13.01M	N/A	N/A	N/A

The Oncology Institute, Inc. Fair Value Envelope

TOI · NASDAQ

Our analysis suggests that TOI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.23, this represents a potential HIDDEN relative to our calculated worth for The Oncology Institute, Inc..

HIDDEN

Intrinsic Value

Current Price: $4.23

Related Guides

Blog Categories

Continue your TOI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.